Srihari S. Naidu, MD, FACC, FSCAI

******Effective September 15, 2016, Dr. Naidu will be taking on an expanded position as Director of Interventional Innovation and the Multi-Center Hypertrophic Cardiomyopathy Program, with offices in BOTH Long Island and Westchester.


He will have full privileges to continue to take care of patients at BOTH

Winthrop University Hospital and Westchester Medical Center.


The HCM Center of Excellence will no longer be at Winthrop.  It will follow me to the new Long Island office below:


Long Island: 877 Stewart Avenue, Garden City, NY  516-307-9388

Westchester: 100 Woods Road, Valhalla, NY  914-909-6900

Scheduler: Belinda Izquierda

Coordinators: Nicole Goldman and Noemi Mercado


If you have trouble scheduling an appointment, please email me directly at ssnaidu@winthrop.org.  I apologize for any confusion during this transition.******

 


 

at


****** PLEASE NOTE EMPLOYMENT TRANSITION MESSAGE ABOVE.  THIS IS MEANT TO BE A SMOOTH TRANSITION FOR PATIENTS BUT ANY DIFFICULTY PLEASE CONTACT ME DIRECTLY ******



Srihari S. Naidu, MD, is an interventional cardiologist with expertise in both the minimally-invasive treatments of heart disease and hypertrophic cardiomyopathy, the most common cause of death in athletes and a common cause of heart failure at all ages.  He is skilled in atrial septal defect (ASD) and patent foramen ovale (PFO) closure, alcohol septal ablation for hypertrophic obstructive cardiomyopathy, aortic and mitral valvuloplasty (and mitraclip percutaneous valve repair), ventricular assist devices, and coronary intervention including angioplasty and stent placement.  He is Board Certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology.

Prior to joining Westchester Medical Center in 2016, Dr. Naidu was an Assistant Professor of Medicine at New York Presbyterian Hospital - Weill Cornell Medical Center and then an Associate Professor of Medicine at SUNY Stony Brook.  Dr. Naidu developed the Hypertrophic Cardiomyopathy Treatment Center at Cornell, performing their first series of alcohol septal ablations, and then grew it to over 800 patients and over 120 alcohol ablations while making it a national Center of Excellence at Winthrop.  Dr. Naidu trained in Internal Medicine at Cornell, and General and Interventional Cardiology at the University of Pennsylvania.  


A graduate of the 8-year Program in Liberal Medical Education at Brown University, Dr. Naidu is Past President of the Medical School Board of Directors, and Reunion Chair of the Undergraduate Class of 1993.   (www.brown.edu/academics/medical/gateway/alumni/brown-medical-alumnI-association/board-of-directors).  He currently serves as Trustee on the Brown University Corporation.

In 2016, Dr. Naidu was recruited to Westchester Medical Center to be Director of Interventional Innovation and Director of the Multi-Center HCM Program, with Divisions in Long Island and Westchester.  As such, he hopes to widen the reach and reputation of both the HCM program and the interventional cardiology services.  With respect to HCM in particular, the Center will have two offices for patients, and will serve one of the largest regions of the country, spanning Upstate NY, Western MA, Western CT, Long Island, the five boroughs of NYC, and parts of Northern and Central NJ.  

A Fellow of the American College of Cardiology (FACC), American Heart Association (FAHA), and Society for Cardiovascular Angiography and Interventions (FSCAI), Dr. Naidu serves on several national committees, including the ACC Interventional Science Council (two term member) and Curriculum Development Work Group, and is an Associate Director for TCT.  Dr. Naidu Founded the SCAI Emerging Leader Mentorship (ELM) Program in partnership with ACC and the Cardiovascular Research Foundation (CRF), a dedicated interventional leadership pipeline that selects and mentors 10 interventional cardiologists every 2 years for national leadership roles.  He is currently Co-Chair of Development for SCAI.

 

Dr. Naidu has over 100 scientific publications, and regularly lectures throughout the United States.  He is the Editor of a textbook on Hypertrophic Cardiomyopathy through Springer Publishing. In addition, he routinely serves as Invited Speaker for the American College of Cardiology (ACC), American Heart Association (AHA), Transcatheter Cardiovascular Therapeutics (TCT), and Society for Cardiac Angiography and Intervention (SCAI) Scientific Sessions.